** = Publications listed in SCI/SSCI/Pubmed
** Rajesh, R; Mooslechner, AA; Schweighofer, H; Pahernik, S; Lanz, I; Atallah, R; Platzer, W; Aigner, C; Benazzo, A; Angiari, S; Marsh, L; Kwapiszewska, G; Heinemann, A; Bärnthaler, T
Succinate aggravates pulmonary fibrosis through the succinate/SUCNR1 axis.
Am J Physiol Lung Cell Mol Physiol. 2025;
Doi: 10.1152/ajplung.00286.2024
Web of Science
PubMed
FullText
FullText_MUG
** Nayak, BB; Red, I; Schwanzer, J; Teppan, J; Lanz, I; Kienzl, M; Heinemann, A; Douschan, P; Sturm, E
The IL23-Th17 axis in neutrophilic airway inflammation
EUR RESPIR J. Abstracts. 2023; 62(Suppl67):PA2992--ERS International Congress 2023; SEP 9-13, 2023; Milan, ITALY.
Doi: 10.1183/13993003.congress-2023.PA2992
[Oral Communication]
Web of Science
FullText
FullText_MUG
** Rajesh, R; Atallah, R; Lanz, I; Platzer, W; Angiari, S; Marsh, L; Bärnthaler, T; Heinemann, A
Succinate aggravates pulmonary fibrosis through the succinate/SUCNR1 axis.
EUR RESPIR J. Abstracts. 2023; 62(Suppl67):PA2359--ERS International Congress 2023; SEP 9-13, 2023; Milan, ITALY.
Doi: 10.1183/13993003.congress-2023.PA2359
[Poster]
Web of Science
FullText
FullText_MUG
** Rani, A; Baladin, D; Teppan, J; Kienzl, M; Jandl, K; Bärnthaler, T; Lanz, I; Stadler, J; Böhm, E; Prassl, R; Marsche, G
Synthetic HDL-nanodiscs as a drug-candidate in pulmonary inflammation
WIEN KLIN WOCHENSCHR. Abstracts. 2023; 135(19-20):566-566.-47. Jahrestagung der ÖGP - 7. Jahrestagung der ÖGTC; OCT 23-25, 2023; Graz, Austria.
[Poster]
Web of Science
** Rittchen, S; Jandl, K; Lanz, I; Reiter, B; Ferreirós, N; Kratz, D; Lindenmann, J; Brcic, L; Bärnthaler, T; Atallah, R; Olschewski, H; Sturm, EM; Heinemann, A
Monocytes and Macrophages Serve as Potent Prostaglandin D2 Sources during Acute, Non-Allergic Pulmonary Inflammation.
Int J Mol Sci. 2021; 22(21): 11697
Doi: 10.3390/ijms222111697
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Bärnthaler, T; Theiler, A; Zabini, D; Trautmann, S; Stacher-Priehse, E; Lanz, I; Klepetko, W; Sinn, K; Flick, H; Scheidl, S; Thomas, D; Olschewski, H; Kwapiszewska, G; Schuligoi, R; Heinemann, A
Inhibiting eicosanoid degradation exerts antifibrotic effects in a pulmonary fibrosis mouse model and human tissue.
J Allergy Clin Immunol. 2020; 145(3):818-833
Doi: 10.1016/j.jaci.2019.11.032
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Baernthaler, T; Theiler, A; Lanz, I; Thomas, D; Jandl, K; Kwapiszewska, G; Schuligoi, R; Heinemann, A
Inhibiting Prostaglandin E2 Degradation Is Protective in a Mouse Model of Pulmonary Fibrosis
AM J RESP CRIT CARE. 2019; 199: -International Conference of the American-Thoracic-Society; MAY 17-22, 2019; Dallas, TX.
[Poster]
Web of Science
** Theiler, A; Konya, V; Pasterk, L; Maric, J; Bärnthaler, T; Lanz, I; Platzer, W; Schuligoi, R; Heinemann, A
The EP1/EP3 receptor agonist 17-pt-PGE2 acts as an EP4 receptor agonist on endothelial barrier function and in a model of LPS-induced pulmonary inflammation.
Vascul Pharmacol. 2016; 87(4):180-189
Doi: 10.1016/j.vph.2016.09.008
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
** Barnthaler, T; Maric, J; Konya, V; Lanz, I; Platzer, W; Schuligoi, R; Heinemann, A
PGE2 released by alveolar epithelial cells protects the pulmonary endothelial barrier integrity
ALLERGY. 2016; 71: 169-169.-Meeting of the European-Academy-of-Allergy-and-Clinical-Immunology; JUN 11-15, 2016; Vienna, AUSTRIA.
[Poster]
Web of Science
** Konya, V; Maric, J; Jandl, K; Luschnig, P; Aringer, I; Lanz, I; Platzer, W; Theiler, A; Bärnthaler, T; Frei, R; Marsche, G; Marsh, LM; Olschewski, A; Lippe, IT; Heinemann, A; Schuligoi, R
Activation of EP4 receptors prevents endotoxin-induced neutrophil infiltration into the airways and enhances microvascular barrier function.
Br J Pharmacol. 2015; 172(18):4454-4468
Doi: 10.1111/bph.13229
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG